News articles and reporting on synthetic biology.
The company's fourth quarter revenues fell 34 percent as COVID testing dried up, but full-year 2022 revenues grew 52 percent year over year.
Indee Labs, GenScript Partner to Develop DNA Knock-In Tech
The partners will use Indee's Hydropore technology, which uses microfluidic vortex shedding to deliver nucleic acids, proteins, and gene-editing complexes into cells.
Evonetix Raises $24M in Extended Series B Funding Round
The company has now raised over $54 million in total Series B funding and has launched an early-access program for its DNA synthesis technology.
Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates
Twist provided fiscal second quarter revenue guidance of approximately $56.5 million, with $24 million in synbio revenues and $25 million in NGS revenues.
De-Extinction Firm Colossal Biosciences Raises $150M in Series B Round
The company also announced plans to restore and reintroduce the extinct dodo bird through a newly formed avian genomics division.